Grifols (GRFS) EPS (Basic) (QoQ) (2010 - 2020)
Grifols (GRFS) EPS (Basic) (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.31 Bn | 632.55 Bn | 17.26 Bn |
| 2 | AbbVie | 470.15 Bn | 463.58 Bn | 12.70 Bn |
| 3 | Merck | 377.27 Bn | 370.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.88 Bn | 295.19 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.92 Bn | 253.02 Bn | 12.86 Bn |
| 6 | Amgen | 236.83 Bn | 222.84 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn |
| 8 | Pfizer | 160.37 Bn | 148.67 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Grifols | 5.46 Bn | 4.46 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -55.46% |
| Mar 31, 2019 | -75.72% |
| Jun 30, 2018 | -1.36% |
| Mar 31, 2018 | -70.06% |
| Jun 30, 2017 | 2.91% |
| Mar 31, 2017 | 64.74% |
| Dec 31, 2016 | -4.79% |
| Sep 30, 2016 | -22.04% |
| Jun 30, 2016 | -46.81% |
| Mar 31, 2016 | 166.52% |
| Dec 31, 2015 | -7.94% |
| Sep 30, 2015 | 6.01% |
| Jun 30, 2015 | 1.26% |
| Mar 31, 2015 | -75.30% |
| Dec 31, 2014 | 29.89% |
| Sep 30, 2014 | 45.77% |
| Jun 30, 2014 | 86.06% |
| Mar 31, 2014 | -64.75% |
| Dec 31, 2013 | 324.09% |
| Sep 30, 2013 | -6.88% |